These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 28344144)

  • 21. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
    Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-Specific Tailored Intervention Improves INR Time in Therapeutic Range and INR Variability in Heart Failure Patients.
    Gotsman I; Ezra O; Hirsh Raccah B; Admon D; Lotan C; Dekeyser Ganz F
    Am J Med; 2017 Aug; 130(8):982-989. PubMed ID: 28344144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement.
    Hylek EM
    J Thromb Thrombolysis; 2013 Apr; 35(3):333-5. PubMed ID: 23456572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review.
    Tadesse TA; Tegegne GT; Yadeta D; Chelkaba L; Fenta TG
    Thromb J; 2022 Oct; 20(1):58. PubMed ID: 36192776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis.
    Rabea EM; Abbas KS; Awad DM; Elgoweini NH; El-Sakka AA; Mahmoud NH; Abdelazeem B
    Eur J Clin Pharmacol; 2022 May; 78(5):755-763. PubMed ID: 35179616
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.